Company PhaseRx Inc Nasdaq
Equities
US71723F1030
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
nan
%
| 0 | 100.0 % | 0 | nan % | -100.00% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
United Stated
nan
%
| 0 | 100.0 % | 0 | nan % | -100.00% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,690,329 | 11,690,329 ( 100.00 %) | 0 | 100.00 % |
Company contact information
PhaseRx, Inc.
410 West Harrison Street Suite 300
98119, Seattle
+206 805 6300
![address PhaseRx Inc](https://cdn.zonebourse.com/static/address/27737201.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |